Research Article · Full Text

Prognostic Factors Influencing Outcomes in Young Stroke Patients with Atrial Fibrillation: Evidence from a Hospital-Based Cohort Study in China

, ,

1Department of Critical Care Medicine, Tianjin Medical University General Hospital, China
2Department of Emergency, Tianjin Huanhu Hospital, China

Article Information

Clinics Cardiology, Volume 4, Issue 1, Pages 1–12
Received: September 14, 2024
Accepted: October 30, 2024
Published: October 30, 2024
Citation copied successfully.

Abstract

Background : Atrial fibrillation (AF) is the established determinant of ischemic stroke and is linked to high mortality and disease burden. We aimed to assess prognosis at 3 and 12 months after stroke in Chinese patients aged <65 years with AF.

Methods : A total of 230 stroke patients with AF were recruited to this study. Outcomes at 3 and 12 months after stroke and clinical features were assessed.

Results : The rate of mortality, recurrence, and dependence at 3 months after stroke was 13.3%, 5.1%, 23.1%, respectively, while at 12 months after stroke was 17.2%, 19.0%, 36.8%, respectively. At 3 months after stroke, compared POCI, the risk of mortality and dependence increased 5.08 times and 2.27 times in PACI, respectively. Moreover, the risk of recurrence increased 3.71 times and 6.87 times in obesity (with no-obesity as the reference) and smoking (with no smoking as the reference), respectively (all p< 0.05). At 12 months after stroke, the risk of mortality and dependence was 4.04 times and 3.73 times compared POCI, respectively (all P < 0.05). Compared with mild stroke, the risk of mortality increased 2.46 times among sever stroke patients at 12 months after stroke (95% CI: 1.03-11.59; P = 0.044); the risk of dependence will increased 1.86 times and 2.20 times among moderate and sever stroke patients, respectively, compared to POCI stroke patients (all P< 0.05). However, hypertension is not a contributing factor to stroke recurrence in middle aged and young patients with AF (P = 0.112).

Conclusions : This study demonstrates that the mortality and dependency rates among post-stroke patients increase over time, with certain stroke types and high-risk factors significantly elevating health risks. However, arterial blood pressure does not have a significant impact on stroke recurrence. These findings highlight the need to optimize clinical strategies for managing arterial blood pressure, prioritize more influential risk factors, and develop targeted policies for the prevention, treatment, and rehabilitation of stroke and atrial fibrillation.

Keywords

Ischemic stroke Atrial fibrillation Outcomes Risk factors Hypertension

ABBREVIATIONS

AF: Atrial fibrillation; CT: computed Tomography; MRI: Magnetic Resonance Imaging; OCSP: Oxfordshire Community Stroke Project; TACI: Total Anterior Circulation Infarct; PACI: Partial Anterior Circulation Infarct; LACI: lacunar Infarct; POCI: Posterior Circulation Infarct; NIHSS: National Institutes of Health Stroke Scale; BI: Bethel Index; BMI: Body Mass Index; TC: Total Cholesterol; TG: Triglycerides; HDL-C: High-Density Lipoprotein Cholesterol; LDL-C: Low-Density Lipoprotein Cholesterol; FG: Fasting Glucose; HbA1c: Glycosylated Hemoglobin; HR: Hazard Ratios; CI: Confidence Interval; OR: Odds Ratios; VISTA: Virtual International Stroke Trials Archive

BACKGROUND

Stroke, the second leading cause of death, worldwide, has caused increasing numbers of deaths and hospitalizations over the past 20 years [1-4]. At the national level, in 2017, stroke was the leading cause of death, years of life lost, and disability-adjusted life-years in China [5]. Presently, there are 13 million stroke patients in China, and the resultant increases in hospitalization costs are much higher than the gross domestic product growth rate [6]. National data show that, between 2005 and 2016, the proportion of patients under the age of 70 years, in China’s stroke population, has continued to increase, with the age of the incident stroke gradually declining [7]. Thus, the stroke burden among young people in China is increasing, making this a major public health problem.

Atrial fibrillation (AF) is an independent risk factor for ischemic stroke and is associated with a high mortality risk and disease burden [8-11].AF increases the stroke risk by a factor of 5 and is reported, in population studies, to contribute to 13–31% of incident ischemic strokes [12-14].Further, AF-associated strokes are more likely to be fatal or disabling than those not associated with AF, and the stroke risk associated with AF is higher than those for other factors associated with ischemic strokes [10,15-19].Among stroke patients with AF, previous studies have indicated that elderly patients are more likely than younger patients to have poor outcomes, including increased rates of mortality, dependency, and recurrence [20,21].

China’s large population of patients with AF-associated strokes has not, however, resulted in this important stroke type receiving sufficient attention. Thus, in this study, we assessed the outcomes and relevant determinants of AF-associated strokes in young and middle-aged adults, in China.

METHODS Patient selection

We recruited consecutive patients with acute ischemic stroke admitted to the stroke unit, between January 2015 and December 2018, excluding those ≥65 years old and those who experienced transient ischemic attacks. Moreover, patients treated with thrombolysis or endovascular reperfusion were not included in this study. All patients were diagnosed according to the World Health Organization criteria, and diagnoses were confirmed using brain computed tomography or magnetic resonance imaging.

Trained neurologists collected detailed information regarding the patients with acute ischemic stroke, including stroke subtype, stroke severity, previous medical history, lifestyle factors, and 3- and 12-monthpost-stroke outcomes. AF was defined as a previous history of AF or as new-onset AF upon admission.

STROKE SUBTYPE

Upon patient admission, strokes were classified, according to the Oxfordshire Community Stroke Project (OCSP) classification, as total anterior circulation infarcts (TACIs), partial anterior circulation infarcts (PACIs), lacunar infarcts (LACIs), or posterior circulation infarcts (POCIs) [22].

CLINICAL FEATURES

Stroke severity was categorized, using the National Institutes of Health Stroke Scale (NIHSS), as: mild (NIHSS score ≤7), moderate (NIHSS score 8–16), or severe (NIHSS score ≥17) [23]. Each patient’s Bethel index (BI) and modified Rankin scale (mRS) score, upon admission, were also recorded.

The examined stroke risk factors included hypertension, diabetes mellitus, dyslipidemia, brain-supplied arterial stenosis, and obesity (body mass index [BMI] ≥30 kg/m2); lifestyle factors included current smoking (≥1 cigarette per day for ≥1 year) and alcohol consumption (drinking alcohol at least once per week for 1 year).

OUTCOME DEFINITIONS AND FOLLOW-UP PROCESS

The assessed post-stroke outcomes were mortality, recurrence, and dependency at 3 and 12 months, post-stroke. These were assessed using both face-to-face and telephone follow-up interviews. The number of deaths included deaths due to any cause occurring within the follow-up period; death data were obtained from family member reports, including those obtained during telephone follow-up interviews. Recurrence was defined as all new-onset vascular events, including strokes, myocardial infarctions, and venous thromboses, occurring within 30 days after the incident stroke. Information regarding the diagnosis and classification of the recurrent events was obtained from the patient’s medical record. Dependency was defined as a mRS score >2 [16].

Trained neurologists followed-up with all discharged stroke patients at 3, 6, 9, and 12 months after the incident stroke. Information regarding outcomes, medication use, primary risk factor control, and mRS scores was recorded following face-to face or telephone interviews.

STATISTICAL ANALYSIS

1. All included patients were classified into either the AF or non-AF group for the analysis. Continuous variables, including the NIHSS score; BI; mRS; and age are presented as median (range interquartile); between group comparisons were performed using Student’s t-test or the Mann-Whitney U-test. Categorical variables, including OCSP classification, stroke severity, conventional risk factors, and outcomes over different post-stroke periods, are presented as numbers (percentages); between-group comparisons were performed using Kaplan-Meier survival curves. A logistic regression analysis was performed to assess the outcome-associated risk factors for AF patients at 3 and 12 months, after stroke; the results are presented as relative risks (RRs) with 95% confidence intervals (CIs). A multivariate analysis was performed using the statistically significant covariates from the univariate analysis, and are presented as adjusted ORs with 95% CIs. Patients lost to follow-up were excluded from the analyses. All statistical analyses were performed using SPSS version 25.0 (SPSS, Chicago, IL); a two-tailed P-value<0.05 indicated statistical significanResults

PARTICIPANTS

We recruited all consecutive acute ischemic stroke patients admitted to the stroke unit in Tianjin, China, between January 2015 and December 2018, excluding those aged 65 years and older and those who experienced transient ischemic attack. Moreover, patients treated with thrombolysis or endovascular reperfusion were not included in this study. Finally, total of 230 AF patients data were selected from the registered patients for analysis.

There were 151 (65.7%) male patients and 79 (34.3%) female patients. In this study, PACI accounts for the largest proportion of OCSP classification (60.3%). The proportion of male patients with mild stroke severity is the largest (47.0%), while female patients with more severe (40.5%). The score of NIHSS was significantly higher in women than in men (13> 8; P=0.001). The score of BI was significantly lower in women than in men (20< 55; P=0.002). Moreover, the smoking and drinking rate of men was significantly higher than that of women (all P< 0.001) [Table 1].

Table 1. The clinical features and previous history of diseases in ischemic stroke patients aged <65 years by AF.

Characteristics

Men

Women

P

Total, n (%):

151 (65.7)

79 (34.3)

Age, mean(SD)

56.20 (7.15)

58.73 (4.33)

0.004

OCSP classification, n (%):

0.016

PACI

89 (59.3)

49 (62.0)

TACI

30 (20.0)

17 (21.5)

LACU

-

4 (5.1)

POCI

31 (20.7)

9 (11.4)

Stroke severity, n (%):

0.032

Mild

71 (47.0)

24 (30.4)

Moderate

40 (26.5)

23 (29.1)

Severe

40 (26.5)

32 (40.5)

Neurological function, median (range):

NIHSS

8 (15)

13 (14)

0.001

BI

55 (70)

20 (65)

0.002

mRS

4 (3)

4 (2)

<0.001

Conventional risk factors, n (%):

Hypertension

92 (60.9)

48 (60.8)

0.980

Diabetes

35 (23.2)

22 (27.8)

0.436

Dyslipidemias

45 (29.8)

25 (31.6)

0.773

Artery stenosis

15 (9.9)

14 (17.7)

0.091

Obesity

19 (12.6)

15 (19)

0.194

Current smoking

70 (46.4)

6 (7.6)

<0.001

Alcohol consumption

36 (23.8)

2 (2.5)

<0.001

Hyperhomocysteinemia

28 (18.5)

8 (10.1)

0.095

Influencing factors related to stroke prognosis in univariate analysis

At 3 months after stroke, the mortality rate and dependence rate were significantly higher in TACI groups, severe stroke group and obesity groups (all P< 0.05). The recurrence rate was higher among obesity than without obesity patients (16.0%>3.5%, P=0.008); higher among smoking patients than never smoking patients (11.8%>1.6%, P=0.002) [Table 2].

Table 2. The risk factors of mortality, dependency, and recurrence at 3 months after stroke among patients aged < 65 years.

Factors

Mortality

Recurrence

Dependency

Values

P

Values

P

Values

P

Total, n (%):

30 (13.3)

10 (5.1)

52 (23.1)

Gender, n (%):

0.474

0.358

0.688

Men

18 (12.2)

8 (6.2)

33 (22.3)

Women

12 (15.6)

2 (3.1)

19 (24.7)

Age, mean(SD)

57.93 (5.32)

0.404

55.20 (5.88)

0.414

57.62 (5.10)

0.445

OCSP classification, n (%):

<0.001

0.554

<0.001

PACI

8 (5.9)

5 (3.9)

22 (16.3)

TACI

16 (34.8)

3 (10.0)

21 (45.7)

LACU

-

-

-

POCI

5 (12.8)

2 (5.9)

8 (20.5)

Stroke severity, n (%):

0.004

0.871

0.004

Mild

6 (6.4)

5 (5.7)

14 (14.9)

Moderate

7 (11.7)

2 (3.8)

12 (20.0)

Severe

17 (23.9)

3 (5.6)

26 (36.6)

Hypertension

0.121

0.447

0.139

Yes

22 (16.2)

7 (6.1)

36 (26.5)

No

8 (9.0)

3 (3.7)

16 (18.0)

Diabetes

0.125

0.071

0.764

Yes

11 (19.3)

-

14 (24.6)

No

19 (11.3)

10 (6.7)

38 (22.6)

Dyslipidemias

0.977

0.469

0.555

Yes

9 (13.2)

2 (3.4)

14 (20.6)

No

21 (13.4)

8 (5.9)

38 (24.2)

Artery stenosis

0.663

0.213

0.236

Yes

3 (10.7)

-

4 (14.3)

No

27 (13.7)

10 (5.9)

48 (24.4)

Obesity

0.046

0.008

0.051

Yes

8 (24.2)

4 (16.0)

12 (36.4)

No

22 (11.5)

6 (3.5)

40 (20.8)

Current smoking

0.107

0.002

0.762

Yes

6 (8.1)

8 (11.8)

18 (24.3)

No

24 (15.9)

2 (1.6)

34 (22.5)

Alcohol consumption

0.121

0.862

0.052

Yes

2 (5.4)

2 (5.7)

4 (10.8)

No

28 (14.9)

8 (5.0)

48 (25.5)

Hcy

0.770

0.188

0.614

Yes

4 (11.8)

3 (10.0)

9 (26.5)

No

26 (13.6)

7 (4.2)

43 (22.5)

At 12 months after stroke, high mortality and dependence rate were found in the TACI and severe stroke patients (all P< 0.001). Moreover, the mortality rate was higher in hypertension patients (22.0%>10.5%, P=0.030), diabetes patients (26.4%> 14.1%, P=0.040). In addition, the dependence rate was higher in obesity patients (58.6%> 33.3%, P=0.009). However, the rate of mortality was lower among current smoking patients than no smoking patients (9.2%< 20.8%, P= 0.040); the rate of dependence was lower among current drinking patients than no drinking patients (14.7%< 41.1%, P= 0.003) [Table 3].

Table 3. The risk factors of mortality, dependency, and recurrence at 12 months after stroke among patients aged < 65 years.

Factors

Mortality

Recurrence

Dependency

Values

P

Values

P

Values

P

Total, n (%):

36 (17.2)

33 (19.0)

77 (36.8)

Gender, n (%):

0.494

0.624

0.143

Men

22 (15.9)

21 (17.9)

46 (33.3)

Women

14 (19.7)

12 (21.1)

31 (43.7)

Age, mean(SD)

57.97 (5.11)

0.319

54.00 (7.79)

0.008

56.73 (6.33)

0.662

OCSP classification, n (%):

<0.001

0.052

<0.001

PACI

10 (8.3)

16 (14.3)

30 (24.8)

TACI

18 (40.0)

9 (33.3)

30 (66.7)

LACU

-

2 (50.0)

2 (50.0)

POCI

7 (18.4)

6 (19.4)

14 (36.8)

Stroke severity, n (%):

<0.001

0.064

<0.001

Mild

6 (6.9)

10 (12.2)

17 (19.5)

Moderate

9 (16.7)

13 (28.9)

21 (38.9)

Severe

21 (30.9)

10 (21.3)

39 (57.4)

Conventional risk factors, n (%):

Hypertension

0.030

0.532

0.283

Yes

27 (22.0)

20 (20.6)

49 (39.8)

No

9 (10.5)

13 (16.9)

28 (32.6)

Diabetes

0.040

0.099

0.876

Yes

14 (26.4)

4 (10.0)

20 (37.7)

No

22 (14.1)

29 (21.6)

57 (36.5)

Dyslipidemias

0.589

0.103

0.505

Yes

9 (15.0)

5 (11.5)

20 (33.3)

No

27 (18.1)

27 (22.1)

57 (38.3)

Artery stenosis

0.982

0.900

0.111

Yes

4 (17.4)

4 (20.0)

5 (21.7)

No

32 (17.2)

29 (18.8)

72 (38.7)

Obesity

0.111

0.231

0.009

Yes

8 (27.6)

6 (28.6)

17 (58.6)

No

28 (15.6)

27 (17.6)

60 (33.3)

Current smoking

0.040

0.286

0.361

Yes

6 (9.2)

14 (23.3)

21 (32.3)

No

30 (20.8)

19 (16.7)

56 (38.9)

Alcohol consumption

0.056

0.302

0.003

Yes

2 (5.9)

4 (12.5)

5 (14.7)

No

34 (19.4)

29 (20.4)

72 (41.1)

Hcy

0.671

0.795

0.326

Yes

5 (14.7)

6 (20.7)

10 (29.4)

No

31 (17.7)

27 (18.6)

67 (38.3)

DISCUSSION

This large, hospital-based study explored the determined factors related to stroke outcomes at 3 and 12 months among young and middle-aged AF patients in China. The rate of mortality, recurrence, and dependence at 3 months after stroke was 13.3%, 5.1%, 23.1%, respectively, while at 12 months after stroke was 17.2%, 19.0%, 36.8%, respectively. In this study, the severity of stroke in men with AF was less severe than in women. At 3 months after stroke, PACI will increase the risk of mortality and dependence; the risk of recurrence was higher in obesity and smoking patients. Moreover, the risk of mortality and dependence at 12 months after stroke increased among PACI and severe stroke patients. While with increasing age, the risk of recurrence decreased at 12 months after stroke; drinking alcohol also reduced the risk of stroke disability at 12 months.

A cohort study including 11 stroke centers in Ontario, Canada reported that the 12 months case fatality was 23.6% [15]. A multinational hospital-based registry from European Community Stroke Project reported that the 3 months mortality rate was 32.8% after stroke [24]. North Dublin Population Stroke Study reported that the 5-year mortality rate in patients with AF is as high as 60.8% after stroke [21]. In this study, the all case of mortality after stroke at 3 months and12 months was 13.3% and 17.2%, respectively. This data was lower than previous studies about AF-stroke mortality. First of all, the follow-up time of this study is only 1 year, and it is younger than the study population in the above study. Secondly, the research area is Tianjin, China. The overall medical level is higher, which may be the reason for the lower mortality rate. Thus, a longer follow-up and multi-center joint study are needed to verify the results of the study.

Elderly stroke patients are more likely than younger patients to have poor outcomes after acute ischemic stroke, and they show greater short- and long-term mortality and dependency rates and a higher risk of stroke recurrence than young patients do [25-28]. A previous study have proved that age was predictors of poor post-stroke prognoses among AF patients [29]. However, the results of this study are contrary to previous studies. In this study, the risk of stroke recurrence decreased with increasing age at 12 months after stroke. The specific mechanism is not clear. The potential cause is that the research population is young and middle-aged, work and life burdens are relatively heave, but as the age increases, life pressure gradually decreases. A meta-analysis which included 6 prospective cohort studies reported that high strain jobs were associated with increased 22% risk of stroke compared with low strain jobs [30].

It is well known that obesity paradox exists in many chronic disease [31,32]. A cohort study in Denmark showed that compared with normal-weight patients, the risk of ischemic stroke was significantly higher in overweight [33]. A previous study reported that in patients with AF over 70 years of age, obesity will increase the risk of stroke, but it has no effect on the mortality after stroke [34]. In addition, a systematic review reported that obesity paradox existed in AF patients, particularly for all-cause and cardiovascular death outcomes [35]. In this study, obesity was the risk factor of recurrence at 3 months after stroke among AF patients. It may be due to the obesity paradox that mostly appears in the elderly, but the research population is young and middle-aged under 65.

Some studies have shown that heavy alcohol consumption increased the mortality rate of stroke [36,37]. Another previous study had also shown no strong associations between alcohol consumption and the functional outcome after stroke among AF patients [38]. A report from the China atrial fibrillation registry study showed that drinkers was associated with lower risk of poor prognosis at 2.5 years after stroke but without significance [39]. However, in this study, current drinking was protect factors of dependence at 12 months after stroke among AF patients. That may be related to the amount of alcohol consumed and the type of alcoholic beverage.

In this study, smoking and sever stroke was risk factors for poor prognosis after stroke. This result was consistent with previous research results. Many studies had reported that smoking will increase the risk of mortality and recurrence of stroke among AF patients [10,39]. Moreover, severe stroke can predict poor prognosis [14,23]. This study results were consistent with previous studies.

There were several limitations in this study. First, all patients in this study were recruited from the same city, which might limit the generalizability of the results in China. Second, there was a lack of pre-stroke information regarding anticoagulation use between the two groups, which may have affected outcome evaluation. However, the impact may be insignificant due to the lower proportion of using anticoagulation medications in China. Finally, this study did not conduct a quantitative analysis of drinking, and future follow-up will improve relevant information.

CONCLUSION

In this large, hospital-based stroke registry, we assessed differences in clinical features, risk factors, and outcomes at 3 and 12 months after stroke among young and middle-aged stroke patients with AF. Sever stroke, obesity, and smoking related to poor prognosis at 3 months after stroke in patients with AF, while drinking alcohol can reduce the dependency rate at 12 months after stroke in patients with AF. Hypertension is not a contributing factor to stroke recurrence in middle aged and young patients with AF. Although the underlying mechanism requires more in-depth basic research, these findings have guiding significance for the prediction of stroke prognosis in young and middle-aged patients with AF.

DECLARATIONS

Ethics approval and consent to participate

This study design was approved by the ethics committee of the Ethics Committee of Tianjin Medical University General Hospital; written and informed consent was obtained from each patient or a family member or other legal guardian.

AVAILABILITY OF DATA AND MATERIALS

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

COMPETING INTERESTS

The authors declare that they have no competing interests.

AUTHORS’ CONTRIBUTIONS

JL and YF were involved in conception and design, and critical review for this article. JL was involved in data analysis for this article and manuscript drafting. Y.F. and K.X. were involved in data collection, case diagnosis and confirmation for this article. All authors reviewed the manuscript.

ACKNOWLEDGEMENTS

We thank all participants in this study.

How to Cite

Jie Liu, Keliang Xie, Yunhan Fei. Prognostic Factors Influencing Outcomes in Young Stroke Patients with Atrial Fibrillation: Evidence from a Hospital-Based Cohort Study in China. Clinics Cardiology; 4(1):1–12.

References

1
Redon J, Olsen MH, Cooper RS, Zurriaga O, MartinezBeneito MA, Laurent S, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011; 32: 1424-31.
URL: https://pubmed.ncbi.nlm.nih.gov/21487117/
2
2. Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015; 45:161-76.
URL: https://pubmed.ncbi.nlm.nih.gov/26505981/
3
3. GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18: 439-458.
URL: https://pubmed.ncbi.nlm.nih.gov/30871944/
4
4. Kunz WG, Hunink MG, Almekhlafi MA, Menon BK, Saver JL, Dippel DWJ, et al. Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke. Neurology. 2020; 95: e2465-e2475.
URL: https://pubmed.ncbi.nlm.nih.gov/32943483/
5
5. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394: 1145-1158.
URL: https://pubmed.ncbi.nlm.nih.gov/31248666/
6
6. Ma LY, Chen WW, Gao RL, Liu LS, Zhu ML, Wang YJ, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol. 2020; 17: 1-8.
URL: https://pubmed.ncbi.nlm.nih.gov/32133031/
7
Wang Longde, Liu Jianmin, Yang Yi, Peng Bin, Wang Yilong. Stroke prevention and treatment in my country still faces huge challenges - Summary of “China Stroke Prevention and Treatment Report 2018”. Chinese Journal of Circulation. 2019; 34: 105-119.
8
8. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001; 37: 371-8.
URL: https://pubmed.ncbi.nlm.nih.gov/11216949/
9
9. Dorian P, Kongnakorn T, Phatak H, Rublee DA, Kuznik A, Lanitis T, et al. Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Eur Heart J. 2014; 35: 1897-906.
URL: https://pubmed.ncbi.nlm.nih.gov/24513791/
10
10. Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial fibrillation. Lancet. 2016; 388: 806-17.
URL: https://pubmed.ncbi.nlm.nih.gov/27560276/
11
11. Ahmadi M, Laumeier I, Ihl T, Steinicke M, Ferse C, Endres M, et al. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial. Lancet Neurol. 2020; 19: 49-60.
URL: https://pubmed.ncbi.nlm.nih.gov/31708447/
12
12. European Registers of Stroke (EROS) Investigators, Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D,Ryglewicz, et al. Incidence of stroke in Europe at the beginning of the 21st century. Stroke. 2009; 40: 1557-63.
URL: https://pubmed.ncbi.nlm.nih.gov/19325154/
13
13. Kelly PJ, Crispino G, Sheehan O,Kelly L, Marnane M, Merwick A, et al. Incidence, event rates, and early outcome of stroke in Dublin, Ireland: the North Dublin population stroke study. Stroke. 2012; 43: 2042-7.
URL: https://pubmed.ncbi.nlm.nih.gov/22693134/
14
14. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick, Moore A, et al. Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis. 2010; 29: 43-9.
URL: https://pubmed.ncbi.nlm.nih.gov/19893311/
15
15. Saposnik G, Hill MD, O’Donnell M, Fang J, Hachinski V, Kapral MK, et al. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke. 2008; 39: 2318-24.
URL: https://pubmed.ncbi.nlm.nih.gov/18566303/
16
16. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007; 38: 1091-6.
URL: https://pubmed.ncbi.nlm.nih.gov/17272767/
17
17. Roquer J, Campello AR, Gomis M. Sex differences in first- ever acute stroke. Stroke. 2003; 34: 1581-5.
URL: https://pubmed.ncbi.nlm.nih.gov/12805490/
18
18. Stuart-Shor EM, Wellenius GA, DelloIacono DM, Mittleman MA. Gender differences in presenting and prodromal stroke symptoms. Stroke. 2009; 40: 1121-6.
URL: https://pubmed.ncbi.nlm.nih.gov/19211480/
19
19. Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009; 38: 4-5.
URL: https://pubmed.ncbi.nlm.nih.gov/19141505/
20
20. Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J et al. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation. 2019; 140: 1834-1850.
URL: https://pubmed.ncbi.nlm.nih.gov/31765261/
21
21. Hayden DT, Hannon N, Callaly E,Chroinin DN, Horgan G, Kyne L et al. Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study. Stroke. 2015; 46: 3488-93.
URL: https://pubmed.ncbi.nlm.nih.gov/26470776/
22
22. Mead GE, Wardlaw JM, Dennis MS, Lewis SC, Warlow CP. Relationship between pattern of intracranial artery abnormalities on transcranial doppler and Oxfordshire Community Stroke Project clinical classification of ischemic stroke. Stroke. 2000; 31: 714-9.
URL: https://pubmed.ncbi.nlm.nih.gov/10700509/
23
23. Kim JS, Lee KB, Roh H, Ahn MY, Hwang HW. Gender differences in the functional recovery after acute stroke. J Clin Neurol. 2010; 6: 183-8.
URL: https://pubmed.ncbi.nlm.nih.gov/21264198/
24
24. Lamassa M, Di Carlo A, Pracucci G, Basile AM, Trefoloni G, Vanni P et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001; 32: 392-8.
URL: https://pubmed.ncbi.nlm.nih.gov/11157172/
25
25. Romero JR, Wolf PA. Epidemiology of Stroke: Legacy of the Framingham Heart Study. Glob Heart. 2013; 8: 67-75.
URL: https://pubmed.ncbi.nlm.nih.gov/23527318/
26
26. Palnum KD, Petersen P, Sørensen HT, Ingeman A, Mainz J, Bartels P et al. Older patients with acute stroke in Denmark: quality of care and short-term mortality. A nationwide follow-up study. Age Ageing. 2008; 37: 90-5.
URL: https://pubmed.ncbi.nlm.nih.gov/17965039/
27
27. Marini C, Baldassarre M, Russo T, Santis FD, Sacco S, Ciancarelli I et al. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology. 2004; 62: 77-81.
URL: https://pubmed.ncbi.nlm.nih.gov/14718701/
28
28. Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver L et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation. 2010; 121: 879-91.
URL: https://pubmed.ncbi.nlm.nih.gov/20142445/
29
29. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005; 366: 1773-83.
URL: https://pubmed.ncbi.nlm.nih.gov/16298214/
30
30. Huang Y, Xu S, Hua J, Zhu D, Liu C, HU Y et al. Association between job strain and risk of incident stroke: A meta- analysis. Neurology. 2015; 85: 1648-54.
URL: https://pubmed.ncbi.nlm.nih.gov/26468409/
31
31. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff AM, Skali H et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007; 116: 627-36.
URL: https://pubmed.ncbi.nlm.nih.gov/17638930/
32
Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007; 120: 863-70.
URL: https://pubmed.ncbi.nlm.nih.gov/17904457/
33
33. Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med. 2013; 126: e9-17.
URL: https://pubmed.ncbi.nlm.nih.gov/23601271/
34
34. Wang HJ, Si QJ, Shan ZL, Guo YT, Lin K, Zhao XN et al. Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience. PLoS One. 2015; 10: e0123516.
URL: https://pubmed.ncbi.nlm.nih.gov/25848965/
35
35. Proietti M, Guiducci E, Cheli P, Lip GY. Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. Stroke. 2017; 48: 857-866.
URL: https://pubmed.ncbi.nlm.nih.gov/28265017/
36
36. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health. 2010; 10: 258.
URL: https://pubmed.ncbi.nlm.nih.gov/20482788/
37
37. Rist PM, Berger K, Buring JE, Kase CS, Gaziano JM, KurthT. Alcohol consumption and functional outcome after stroke in men. Stroke. 2010; 41: 141-6.
URL: https://pubmed.ncbi.nlm.nih.gov/19910548/
38
38. Wang YF, Lu SX, Xia SJ, Jia ZX, Jiang C, He L et al. [Risk factors for recurrent hospitalizations of patients with atrial fibrillation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48: 308-314.
URL: https://pubmed.ncbi.nlm.nih.gov/32370482/
39
39. Jiang C, Lan DH, Du X, Geng YP, Chang SS, Zheng D et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study. J Cardiovasc Electrophysiol. 2019; 30: 2759-2766.
URL: https://pubmed.ncbi.nlm.nih.gov/31599040/
No Image

Author Name

Departments: